Which vaccines are conjugate vaccines because they pair a polysaccharide with a protein to enhance immunogenicity?

• A. Tetanus toxoid vaccine.
• B. Varicella vaccine.
• C. Haemophilus influenzae type b and pneumococcal vaccines.
• D. Influenza vaccine.

Answer: (C)

Conjugate vaccines boost responses to polysaccharide capsules by attaching the sugar to a protein carrier, turning a typically T-independent stimulus into a T-dependent one. This engages helper T cells, enabling class switching, affinity maturation, and lasting immune memory, which is especially important in young children.

Haemophilus influenzae type b and pneumococcal vaccines use this approach: their polysaccharide capsules are linked to a protein carrier (often a tetanus or diphtheria toxoid or a similar protein). This conjugation makes the immune system respond more robustly and develop memory against these bacteria.

The other options don’t use this strategy. A tetanus toxoid vaccine is based on the toxin protein itself, not a polysaccharide-protein conjugate; varicella is a live attenuated virus vaccine; influenza vaccines are generally inactivated or recombinant viral proteins, not conjugated polysaccharides.